Evaluación económica de medicamentos y tecnologías sanitarias: (Record no. 104072)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 03921nam a22004215i 4500 |
| 001 - CONTROL NUMBER | |
| control field | 978-84-940346-6-4 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | DE-He213 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20140220083334.0 |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr nn 008mamaa |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 140110s2012 sp | s |||| 0|spa d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9788494034664 |
| -- | 978-84-940346-6-4 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/978-84-940346-6-4 |
| Source of number or code | doi |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | R1 |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MB |
| Source | bicssc |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED000000 |
| Source | bisacsh |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 610 |
| Edition number | 23 |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Soto Álvarez, Javier. |
| Relator term | author. |
| 245 10 - TITLE STATEMENT | |
| Title | Evaluación económica de medicamentos y tecnologías sanitarias: |
| Medium | [electronic resource] : |
| Remainder of title | Principios, métodos y aplicaciones en política sanitaria / |
| Statement of responsibility, etc | by Javier Soto Álvarez. |
| 264 #1 - | |
| -- | Madrid : |
| -- | Springer Healthcare Iberica : |
| -- | Imprint: Springer Healthcare, |
| -- | 2012. |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | VIII, 328 p. 44 illus., 2 illus. in color. |
| Other physical details | online resource. |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 347 ## - | |
| -- | text file |
| -- | |
| -- | rda |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Fundamento e introducción a la evaluación económica de medicamentos y tecnologías sanitarias -- Estandarización en el diseño y realización de evaluaciones económicas: recomendaciones y guías existentes -- Tipos de costes a incluir en una evaluación económica -- Medición y evaluación de los resultados en salud en las evaluaciones económicas -- Estudios de coste de la enfermedad -- Análisis de minimización de costes y análisis coste-consecuencia -- Análisis coste-beneficio -- Análisis coste-efectividad -- Análisis coste-utilidad -- Análisis de impacto presupuestario -- Análisis e interpretación de los resultados de las evaluaciones económicas. Reglas de decisión -- Diseño y realización de evaluaciones económicas a través de modelos analíticos de decisión -- Incorporación de evaluaciones económicas en ensayos clínicos y diseños observacionales -- Análisis de sensibilidad y manejo de la incertidumbre en las evaluaciones económicas -- Revisión crítica de la calidad de evaluaciones económicas publicadas -- Revisiones sistemáticas de evaluaciones económicas publicadas -- Transferencia y adaptación de los resultados de evaluaciones económicas efectuadas en un país y entorno sanitario a otros diferentes -- Uso y aplicaciones de las evaluaciones económicas en la elaboración de políticas sobre medicamentos y tecnologías sanitarias en el Sistema Nacional de Salud de nuestro país. |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | The ultimate purpose of this book on economic evaluation is to be a text for consultation and inspiration to anyone who wishes to design, carry out and analyse an economic evaluation of a drug or health technology, in order to obtain valid and quality results and thus serve to make better health-related decisions in our country. Unfortunately, the resources available in our National Health System to cover all the healthcare needs of our society are ever more limited; therefore, it is absolutely necessary to prioritise the allocation of resources and to use these resources to finance the therapeutic options that are most efficacious, safe and cost-effective (that will achieve the best health results in patients with the monetary investment carried out). Economic evaluations will be instruments of invaluable help for healthcare professionals and other decision-making agents of the system when it comes to making a more efficient use of existing resources, maximising the therapeutic benefit. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Economics. |
| 650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine & Public Health. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Medicine/Public Health, general. |
| 650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Economics/Management Science, general. |
| 710 2# - ADDED ENTRY--CORPORATE NAME | |
| Corporate name or jurisdiction name as entry element | SpringerLink (Online service) |
| 773 0# - HOST ITEM ENTRY | |
| Title | Springer eBooks |
| 776 08 - ADDITIONAL PHYSICAL FORM ENTRY | |
| Display text | Printed edition: |
| International Standard Book Number | 9788494034619 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | http://dx.doi.org/10.1007/978-84-940346-6-4 |
| 912 ## - | |
| -- | ZDB-2-SME |
No items available.